Increased incidence of inflammatory bowel disease in Québec residents with airway diseases

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 962-968

  Brassard, Paul ^a,b   Vutcovici, Maria ^c   Ernst, Pierre ^a,b   Patenaude, Valérie ^a   Sewitch, Maida ^b,c   Suissa, Samy ^a,b   Bitton, Alain ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANADA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ULCERATIVE COLITIS; AGE DISTRIBUTION; COLITIS, ULCERATIVE; COMORBIDITY; COMPARATIVE STUDY; FACTUAL DATABASE; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; RISK ASSESSMENT; SEX RATIO; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; ASTHMA; COHORT STUDIES; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUEBEC; RESPIRATION DISORDERS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84926443284     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00079414     Document Type: Article

References (31)

1. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836.
2. Ekbom A, Brandt L, Granath F, et al. Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung 2008; 186: 167-172.
3. Hemminki K, Li X, Sundquist J, et al. Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?. Ann Epidemiol 2010; 20: 217-222.
4. Weng X, Liu L, Barcellos LF, et al. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol 2007; 102: 1429-1435.
5. Tzanakis NE, Tsiligianni IG, Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010; 16: 299-305.
6. Benard A, Desreumeaux P, Huglo D, et al. Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol 1996; 97: 1173-1178.
7. Raj AA, Birring SS, Green R, et al. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008; 102: 780-785.
8. Virta LJ, Ashorn M, Kolho KL, et al. Cow's milk allergy, asthma, and pediatric IBD. J Pediatr Gastroenterol Nutr 2013; 56: 649-651.
9. Lowe AM, Roy PO, Bigras-Poulin M, et al. Epidemiology of Crohn's disease in Quebec, Canada. Inflamm Bowel Dis 2009; 15: 429-435.
10. Bitton A, Vutcovici M, Patenaude V, et al. Epidemiology of inflammatory bowel disease in Quebec: recent trends. Inflamm Bowel Dis 2014; 20: 1770-1776.
11. Statistics Canada. Canadian Community Health Survey - Health Indicator Profile, Annual Estimates, by Age Group and Sex, Canada, Provinces, Territories, Health Regions (2012 boundaries) and Peer Groups (Table 105-0502), 2012. www23.statcan.gc.ca/imdb/p3Variable.pl?Function=getStatDEDataList&DEItem-Id=62231&DECItem-Id=379&Repclass=591&SurvId=3226&SurvVer=2&InstaId=15282&InstaVer=10&t=t&db=imdb Date last updated: December 2, 2013.
12. Canadian Lung Association. Chronic Obstructive Pulmonary Disease (COPD). A National Report Card. Ottawa, Canadian Lung Association, 2005.
13. Pomey MP, Forest PG, Palley HA, et al. Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States. The Milbank Quarterly 2007; 85: 469-498.
14. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol 1995; 48: 999-1009.
15. Brassard P, Suissa S, Kezouh A, et al. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med 2011; 183: 675-678.
16. Ernst P, Baltzan M, Deschênes J, et al. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006; 27: 1168-1174.
17. Ernst P, Gonzalez AV, Brassard P, et al. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176: 162-166.
18. Gonzalez AV, Li G, Suissa S, et al. Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther 2010; 23: 65-70.
19. Suissa S, Baltzan M, Kremer R, et al. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004; 169: 83-88.
20. Hasegawa K, Tsugawa Y, Tsai CL, et al. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respir Res 2014; 15: 40.
21. Marton JP, Boulanger L, Friedman M, et al. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective. Respir Med 2006; 100: 996-1005.
22. Rezaie A, Quan H, Fedorak RN, et al. Development and validation of an administrative case definition for inflammatory bowel diseases. Can J Gastroenterol 2012; 26: 711-717.
23. Statistics Canada. Age and Sex for Population, for Canada, Provinces, Territories and Federal Electoral Districts. www12.statcan.gc.ca/english/census01/products/standard/themes/Rp-eng.cfm?TABID=1&LANG=E&A=R&APATH=3&DETAIL=1&DIM=0&FL=A&FREE=0&GC=24&GID=361266&GK=1&GRP=1&O=D&PID=55436&PRID=0&PTYPE=55430,53293,55440,55496,71090&S=0&SHOWALL=0&SUB=0&Temporal=2001&THEME=37&VID=0&VNAMEE=&VNAMEF=&D1=0&D2=0&D3=0&D4=0&D5=0&D6=0 Date last updated: August 15, 2012.
24. Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 2012; 5: 7-18.
25. Becker KG, Simon RM, Bailey-Wilson JE, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Nat Acad Sci USA 1998; 95: 9979-9984.
26. Schreiber S, Rosenstiel P, Albrecht M, et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6: 376-388.
27. Rutten EP, Lenaerts K, Buurman WA, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 2014; 145: 245-252.
28. Yun HD, Knoebel E, Fenta Y, et al. Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin Proc 2012; 87: 953-960.
29. Juhn YJ. Influence of asthma epidemiology on the risk for other diseases. Allergy Asthma Immunol Res 2012; 4: 122-131.
30. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559-1568.
31. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking. A review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004; 10: 848-859.